Showing results (521-530 of 592) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|July 27, 2006
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk testM H Buch, C P Denton, D E Furst, et al.
Annals of the Rheumatic Diseases|July 3, 2008
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockadeJ S Smolen, C Han, D M F M van der Heijde, et al.
Fetal Diagnosis and Therapy|May 23, 2017
Fetal Treatment 2017: The Evolution of Fetal Therapy Centers - A Joint Opinion from the International Fetal Medicine and Surgical Society (IFMSS) and the North American Fetal Therapy Network (NAFTNet)Anita J Moon-Grady, Ahmet Baschat, Darrell Cass, et al.
Lupus|March 14, 2000
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusM Galeazzi, G D Sebastiani, A Tincani, et al.
Annals of the Rheumatic Diseases|December 19, 2007
A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)S M Churchman, L D Church, S Savic, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness studyP Emery, J E Gottenberg, A Rubbert-Roth, et al.
Lupus|August 2, 2003
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusG D Sebastiani, M Galeazzi, A Tincani, et al.
Annals of the Rheumatic Diseases|September 24, 2016
Treat-to-target (T2T) recommendations for goutU Kiltz, J Smolen, T Bardin, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitisA Calin, B A C Dijkmans, P Emery, et al.
Annals of the Rheumatic Diseases|December 3, 2003
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II studyL B A van de Putte, R Rau, F C Breedveld, et al.
Pageof 60